Coronary artery disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: This study included patients received PCI with either DCB or everolimus-eluting stent (EES) for de-novo large-vessel coronary artery lesions (3.0mm or above) from January 2016 to December 2018.
Exclusion criteria
Exclusion criteria: The following points were excluded from this study: 1) lesions treated with any stents in the target vessel, and 2) procedures including a mixture of DCB and stent implantation in different sites lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of cardiovascular events during 5 years after the index PCI | — |
Countries
Japan
Contacts
Hyogo Prefectural Harima-Himeji General Medical Centre Cardiovascular Medicine